NCT Number: NCT00130858
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
Phase II Study to evaluate the response on two blocks of topotecan and carboplatin
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 21 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
HELIOS Klinikum Erfurt GmbH, Erfurt, Saxony, Germany
About this study
Phase II study for patients with chemosensible soft tissue sarcoma stage IV in children and adolescents ; response according to RECIST criteria following two blocks of combination therapy consisting of Topotecan and carboplatin
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Soft tissue sarcoma chemosensible, stage IV
- age < 21
- measurable tumor lesions
Exclusion criteria
- Lack of cooperation by the patient
- no willingness of follow-up examinations
- participation on another clinical trial at the same time
- death due to the sickness within four weeks
Treatment and study plan
carboplatin
DrugPrimary outcomes
-
Response according to RECIST criteria
Secondary outcomes
-
Toxicity
-
Overall-Survival
-
Event-free-survival
Sponsors and collaborators
Lead sponsor
Cooperative Weichteilsarkom Study Group
Other
Collaborators
- Deutsche Krebshilfe e.V., Bonn (Germany)
Registry information
Important dates
- Study start
- 2005
- Primary completion
- 2007
- Study completion
- 2009
- First posted
- Aug 16, 2005
- Registry last updated
- Apr 2, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
NCT02415816
Myosarcoma, Neoplasms
Memphis, Tennessee, United States
View Trial DetailsStudy of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma
NCT05858710
Neoplasms, Neoplasms by Histologic Type
Berlin, Germany
View Trial DetailsDoxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
NCT02584309
Angiosarcoma, Dermatofibrosarcoma
St Louis, Missouri, United States
View Trial DetailsTranscutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma
NCT02897128
Neoplasms, Neoplasms by Histologic Type
Gainesville, Florida, United States
View Trial Details